1[1]Scholtz M,Duclos P.Immunization safety:a global priority [J].Bulletin of WHO,2000,78:153-154.
2[2]Miller MA,Pisani E.The cost of unsafe injections [J].Bulletin of WHO,1999,77:808-811.
3[3]Metha U,Milstien JB,Duclos P,et al.Developing a national system for dealing with adverse events following immunization [J].Bulletin of WHO,2000,78:170-177.
4[4]Atkinson W,et al.Epidemiology and prevention of vaccine-preventable diseases [M].6th edition.2000.
6Jack AD, Hall A J, Maine N, et al. What level of hepatitis bantibody is protective [ J ]. Infect Dis,2009,179 ( 2 ) : 489 - 492.
7Bowman T, Garcia R,Turkson J, et al. Stats in oneogenesis[ J ]. Oncogene.2007.19(21) :2474 -2488.
8Buettner R, Mora LB, Jove R. Activated stat signalling in human tumors provides novel molecular targets for therapeutic intervention [J]. ain Cancer Res,2004,8(4) :945 -954.
9Yu H, Jove R. The stats of cancer - new molecular targets come of age [ J ]. NatureRevCancer,2010,4 (2) :97 - 105.
10Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 eases among 48,900 necrolasies [ J ]. Cancer, 2008,7 ( 3 ) : 462 - 503.
